Dow Announces Global Commercial Availability of METHOCEL™ Bind at IFFA
Improves Food Stability, Bite and Texture Even at Lower Consumption Temperatures
Today at IFFA -the leading international trade fair for the meat industry- Dow Pharma & Food Solutions, a business unit of The Dow Chemical Company (NYSE: DOW), announced the global commercial availability of METHOCEL™ Bind, a new range of food stabilizers for meat and vegetarian applications. METHOCEL™ Bind is the latest addition to Dow’s METHOCEL™ family of highly versatile plant-based food ingredients (cellulose derivatives) and is designed to help food manufacturers create convenient, healthier, and cost-effective foods by improving stability, bite, and texture at high and low temperatures from production to consumption.
METHOCEL™ Bind creates stable emulsions that offer similar benefits to Dow’s METHOCEL™MX but with improved structure and texture at lower consumption temperature thanks to its lower melt back property and long lasting gelling behavior. This makes METHOCEL™ Bind suitable for cold cuts and foods that require both a hot and cold bite. During thermal gelling some moisture is released, which enhances flavors and leads to a juicy bite at high temperatures.
In addition, emulsions with METHOCEL™ Bind allow food manufacturers to reduce the fat content of meat by up to 50% or replace the animal fats with healthier alternatives such as vegetable and omega oils. Due to its structural functionality, METHOCEL™ Bind can also be used to replace or reduce meat and eggs for healthier food options that satisfy the dietary, religious, health or ethical concerns of consumers without compromising on taste, look and texture.
“We developed METHOCEL™ Bind to help global and regional food manufacturers extend their product offering in the fast growing market segments of meat, meat analogues and vegetarian foods. Our ingredients can be easily integrated into a wide range of formulations to address consumer demands, improve the sensory attributes, and meet the requirements of cost-sensitive markets” comments Dr. Anne Adden, Global Market Manager, Meat and Vegetarian Products.
Earlier this week, Dow already announced the global commercial launch of WELLENCE™ Fat Reduction; a range of innovative cellulose-based food gums that help reduce the oil uptake of coated and battered food products including meat and meat analogues during frying. This allows food manufacturers to achieve a fat and calorie reduction of up to 35% in fried foods, enabling ‘reduced fat claims’ without compromising on product quality and taste.
Dow Pharma & Food Solutions designs differentiated solutions that enable pharmaceutical delivery & nutritional benefits to customers around the world. A business of Dow Consumer Care portfolio, Dow Pharma & Food Solutions offers a single interface to all Dow technologies and expertise focused on solutions serving the pharmaceutical and food manufacturing markets. We provide functional excipients, active pharmaceutical ingredients (APIs) and highly functional food ingredients to help consumers live healthier, more convenient and enjoyable lives. Dow Pharma & Food Solutions employs 1,200 people across nine sites and 15 manufacturing plants, with six cGMP's, serving customers in around 160 countries. Additional details can be found at www.dowpharmaandfood.com.
Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from material, polymer, chemical and biological science to help address many of the world's most challenging problems such as the need for clean water, clean energy generation and conservation, and increasing agricultural productivity. Dow's integrated, market-driven, industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 180 countries and in high-growth sectors such as packaging, electronics, water, coatings and agriculture. In 2015, Dow had annual sales of nearly $49 billion and employed approximately 49,500 people worldwide. The Company's more than 6,000 product families are manufactured at 179 sites in 35 countries across the globe. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.